BRETEC fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. It specializes in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The company's products include bioabsorbable nails, pins, and screws as well as bioresorbable magnesium implants. Bioretec was founded in 1998 and is headquartered in Tampere, Finland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
BRETEC has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company